Multimodal treatment including surgery and chemotherapy is considered the gold standard
treatment of pancreatic cancer by most guidelines. Neoadjuvant therapy (NAT) has been …

Treating older adults with cancer is increasingly important in modern oncology practice.
However, we currently lack the high-quality evidence needed to guide optimal management …

Simple Summary Gemcitabine/nab-paclitaxel (GN) and FOLFIRINOX (FFX) are two standard
first-line therapies for metastatic pancreatic cancer (PC) but have rarely been compared …

Objectives The present multicenter prospective observational study investigated the
effectiveness and safety of neoadjuvant chemotherapy (NAC) for patients with borderline …

Pancreatic cancer, one of the diseases of the elderly, has dismal prognosis, demanding
major surgery with high risk and life quality problems, especially in the elderly. Therefore …

Abstract Background and Objectives Selecting frail elderly patients with pancreatic cancer
(PC) for pancreas resection using biologic age has not been elucidated. This study …

Objectives To investigate the diagnostic performance and interobserver variability in the
determination of arterial invasion in pancreatic ductal adenocarcinoma (PDAC) and …

Background Pancreatic ductal adenocarcinoma (PDAC) typically occurs in an older patient
population. Yet, early-onset pancreatic cancer (EOPC) has one of the fastest growing …